¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023 ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-04-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023 ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-04-08
±³À°ÀÏÀÚ : 2023-04-08
±³À°Àå¼Ò : ¿©¼ö º£³×Ä¡¾Æ È£ÅÚ ÄÁº¥¼Ç·ë

±³À°ÁÖÁ¦ : 2023 ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ(¸íĪº¯°æ 22.9.19 ´ëÇÑ°©»ó¼±³»ºÐºñ¿Ü°úÇÐȸ)
´ã´çÀÚ : ±èÀº¿µ
¿¬¶ôó : 02-501-2988  

À̸ÞÀÏ : kates1996@naver.com

±³À°Á¾·ù : ¿Ü°ú

Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : Àü¶ó³²µµ
±³À°½Ã°£ : 10 ½Ã°£ 50ºÐ

¼¼ºÎ¼ö°­·á : 150,000¿ø  

ºñ°í Æò»ýȸ¿ø : 10¸¸¿ø,12¸¸¿ø(ÇöÀå) Á¤È¸¿ø : 10¸¸¿ø, 12¸¸¿ø(ÇöÀå) Àü°øÀÇ : 7¸¸¿ø, 9¸¸¿ø(ÇöÀå) °£È£»ç : 5¸¸¿ø, 7¸¸¿ø(ÇöÀå) ºñȸ¿ø : 13¸¸¿ø, 15¸¸¿ø(ÇöÀå)


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04-08 ÄÁº¥¼Ç·ë 08:30~09:00 1) New nerve monitoring methods À̺´ÁÖ(ºÎ»êÀÇ´ë À̺ñÀÎÈÄ°ú)

±³À°½Ã°£ 04-08 ÄÁº¥¼Ç·ë 09:00~09:30 2) Newly developed Surgical Robots °­»ó¿í(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04-08 ÄÁº¥¼Ç·ë 09:30~10:00 3) New targeted agents in thyroid cancer treatment ±è¼®¸ð(¿¬¼¼ÀÇ´ë)

ÈÞ½Ä 04-08 10:00~10:20 Coffee Break ()

±³À°½Ã°£ 04-08 ÄÁº¥¼Ç·ë 10:20~10:50 1) Management Skills in medical aspect ±èÅ¿ë(¿ï»êÀÇ´ë ³»°ú)

±³À°½Ã°£ 04-08 ÄÁº¥¼Ç·ë 10:50~11:20 2) Management of post thyroidectomy voice problems À̽¿ø(¼øõÇâÀÇ´ë À̺ñÀÎÈÄ°ú)

±³À°½Ã°£ 04-08 ÄÁº¥¼Ç·ë 11:20~11:50 3) Other complications after thyroid surgery ±èÇü±Ô(¾ÆÁÖÀÇ´ë)

Åä·Ð 04-08 ÄÁº¥¼Ç·ë 11:50~12:20 ÃÑȸ °­°æÈ£(ÀÌÈ­ÀÇ´ë)

½Ä»ç 04-08 12:20~13:20 Lunch ()

±³À°½Ã°£ 04-08 ÄÁº¥¼Ç·ë 13:20~14:20 Review of salivary gland surgery - Parotid gland¸¦ Áß½ÉÀ¸·Î Á¤Á¾±æ(¿©¼öÀü³²º´¿ø)

±³À°½Ã°£ 04-08 ÄÁº¥¼Ç·ë 14:20~15:20 The use of fluorescent techniques for the detection and preservation of the parathyroid glands decreases the rate of post-thyroidectomy hypoparathyroidism Frederic Triponez(Geneva University Hospitals)

ÈÞ½Ä 04-08 15:20~15:40 Coffee Break ()

±³À°½Ã°£ 04-08 ÄÁº¥¼Ç·ë 15:40~16:10 1) Surgical treatment vs. Active Surveillance ±è¿ø¿õ(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04-08 ÄÁº¥¼Ç·ë 16:10~16:40 2) Paradigm Shifting of Extent of Thyroidectomy ÃÖÁØ¿µ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-08 ÄÁº¥¼Ç·ë 16:40~17:10 3) Current practice of active surveillance in Korea - Survey ±è¼ö¿µ(Â÷ÀÇ°ú´ë)

Åä·Ð 04-08 ÄÁº¥¼Ç·ë 17:10~18:00 Panel discussion: ÇÐȸ·Î ¿Â ¾û¶×ÇÑ Áú¹®µé ÀåÇ×¼®(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04-08 Æ佺ŸȦ 08:30~08:40 OP-3-1. Does stress influence urine iodine concentration in patients undergone lobectomy? ÀÌÁ¤ÈÆ(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 04-08 Æ佺ŸȦ 08:40~08:50 OP-3-2. Estradiol effect between thyroid and breast cancer via blood microbiome ¾ÈÁ¤½Å(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 04-08 Æ佺ŸȦ 08:50~09:00 OP-3-3. Metabolic syndrome as a prognostic factor in papillary thyroid cancer patients ¾ÈÇϸ²(ÀüºÏÀÇ´ë)

±³À°½Ã°£ 04-08 Æ佺ŸȦ 09:00~09:10 OP-3-4. Predictive factors for malignancy in patients diagnosed with preoperative follicular neoplasm Á¤¿µÈÆ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-08 Æ佺ŸȦ 09:10~09:20 OP-3-5. Risk factors for structural recurrence in medullary thyroid cancer ¹Ú½ÅÁ¤(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04-08 Æ佺ŸȦ 09:20~09:30 OP-3-6. Effects of neoadjuvant chemoradiotherapy on anaplastic thyroid carcinoma: A single-center experience ÀÌÁø¼®(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04-08 Æ佺ŸȦ 09:30~09:40 OP-3-7. Monitoring of circulating tumor cells on papillary thyroid cancer following thyroidectomy: A prospective cohort study À¯Çü¿ø(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-08 Æ佺ŸȦ 09:40~09:50 OP-3-8. Gene expression changes in the microgravity state of korean thyroid cancer cell lines ¾ÈÁ¾Çõ(ÃæºÏÀÇ´ë)

±³À°½Ã°£ 04-08 Æ佺ŸȦ 09:50~10:00 OP-3-9. A pilot study of a new technique to predict the viability of tissues ±è¿ì¿µ(°í·ÁÀÇ´ë)

ÈÞ½Ä 04-08 10:00~10:20 Coffee Break ()

±³À°½Ã°£ 04-08 Æ佺ŸȦ 10:20~10:50 1) °©»ó¼± ¼ö¼ú Àü/ÈÄÀÇ °©»ó¼±±â´É°Ë»çÀÇ ÀÇ¹Ì ÃÖÇý·Ã(À»ÁöÀÇ´ë)

±³À°½Ã°£ 04-08 Æ佺ŸȦ 10:50~11:20 2) ´Ù¾çÇÑ °©»ó¼±¼ö¼ú Á¢±Ù ¹æ¹ý ÃÖÁ¤Àº(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 04-08 Æ佺ŸȦ 11:20~11:50 3) °©»ó¼± ÀýÁ¦ ÈÄ º¸Á¶Ä¡·á °­»óÀ²(Àü³²ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023 ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-04-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦8ȸ ÇǺΰúÀǻ縦 À§ÇÑ °Ç¼±Ä¡·á¼¼¹Ì³ª : 2023-04-08
´ÙÀ½±Û (¿Â¶óÀÎ) 2023 Á¤½Å½ÅüÀÇÇÐ Àü¹®°¡°úÁ¤ ½Å±Ô±³À° 2ȸ±â : 2023-04-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 11 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 19 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 116 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 27 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 102 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 19 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 13 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 10 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 34 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 8 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 14 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 4 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 12 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 14 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 15 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷